Hone Bio
Targeted lipid nanoparticle delivery technology for biotech and pharmaceutical developers of therapeutics
Highlights
- New on EvolcAdded 2026-11-15
About Hone Bio
Hone Bio develops NanoPilot, a platform that engineers lipid nanoparticles to target specific cell types and reduce off-target liver uptake.
The Bristol-based, VC-backed pre-clinical biotech company develops drug-delivery technology for therapeutic applications. Its team includes scientists, engineers and advisors working on NanoPilot; the company also offers licensing enquiries.
Product: NanoPilot, a targeted lipid nanoparticle delivery platform for extrahepatic drug delivery.
Jobs at Hone Bio
Leadership
- Adam Perriman · CSO & Co-FounderSource: company website
- Josh Bufton · Senior Protein Scientist & Co-FounderSource: company website
- Tom Green · Senior Research Scientist & Co-FounderSource: company website
- Ben Carter · CEO & Co-FounderSource: company website
More biotech & pharma companies
Horizon Discovery Group
Gene-editing reagents, engineered cell lines and reference standards for life sciences research and diagnosticsHvivo Services
Early-phase clinical trials and human challenge studies for biopharma and biotech drug developersHyfacol
Medical-grade collagen manufacturing platform for advanced wound care and guided bone regeneration productsYoung companyNew on EvolcHypha Discovery
Specialist CRO making drug and agrochemical metabolites, purifying compounds and running MetID studies for pharma clientsIgnota Labs
AI-enabled drug rescue and development for pharmaceutical and biotech partners seeking to revive drugs stalled by safety issuesNew on EvolcIlc Therapeutics
Develops hybrid interferon therapeutics, with lead candidate Alfacyte in development as an antiviral for RSV
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-amz-cf-id
- Response headerx-amz-cf-id
- Response headerx-amz-cf-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.